| 【Company Research】Recbio Technology (2179 HK) – Smooth progress of core pipeline products |
| 【Company Research】Wingtech (600745 CH) – 2Q results in line; Maintain BUY |
| 【Company Research】Innolight (300308 CH) – Overseas data center demand to remain resilient in 2H22 |
| 【Company Research】Huitongda Network (9878 HK) – Resilient growth in 2H22 |
| 【Company Research】Innovent Biologics (1801 HK) – Fast expanding commercial product portfolio |
| 【Company Research】Zhejiang Jingsheng (300316 CH) – 2Q22 profit +1.4x YoY with strong cash flow; Raise earnings & TP on solid margin |
| 【Company Research】China Life (2628 HK) – New business volume growth turned positive in 2Q22 |
| 【Fixed Income Research】CARINC: Better than expected 1H22 results. Buy CARINC'24 as a carry play |
| 【Company Research】Nongfu Spring (9633 HK) – 1H22 beat on GPM; tea beverage should continue to drive growth over 2H |
| 【Company Research】SenseTime (20 HK) – A slower AI adoption pace amid macro uncertainties |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
